In liver biopsies obtained from NAFLD patients, the activation of the IRE1α signaling pathway was accompanied by BI-1 downregulation, suggesting that the IRE1α signaling pathway contributed to NAFLD. Here, ERN1 is linked to metabolic dysfunction-associated steatotic liver disease.